Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Comparison of Atezolizumab/Bevacizumab Versus Durvalumab/Tremelimumab (STRIDE) Protocols in Locally Advanced or Metastatic Hepatocellular Carcinoma Among Patients in Suhag Cancer Center, Egypt

NCT07669597 is registered in ClinicalTrials.gov with Sohag Oncology Center as lead sponsor.

NCT NCT07669597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07669597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Comparison of Atezolizumab/Bevacizumab Versus Durvalumab/Tremelimumab (STRIDE) Protocols in Locally Advanced or Metastatic Hepatocellular Carcinoma Among Patients in Suhag Cancer Center, Egypt
Lead sponsor
Sohag Oncology Center
Phase
Observational
Overall status
Active, not recruiting
Start date
March 1, 2026
Completion date
June 1, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced or metastatic hepatoceullar carcinoma